Company Overview
Company Type: Public Company
Website: www.lucyscientific.com
Number of Employees: -
Ticker: LSDI (NasdaqCM)
Year Founded: 2017


Business Description
Lucy Scientific Discovery Inc. engages in the research, development, manufacture, and sale of psychedelic products. It offers biological raw materials, active pharmaceutical ingredients, and finished biopharmaceutical products. The company was formerly known as Hollyweed North Cannabis Inc. and changed its name to Lucy Scientific Discovery Inc. in May 2021. The company was incorporated in 2017 and is headquartered in Victoria, Canada.

Financial Information (Currency: CAD, in mm) 
Market Capitalization
8.1
Total Enterprise Value
5.8
EBIT
(6.2)
Cash & ST Invst.
4.7
P/Diluted EPS Before Extra
NM
Net Income
(10.6)
Total Debt
2.4
Price/Tang BV
0.9x
Total Assets
12.9
Currency in CAD in mm, LTM as of Mar-31-2023 TEV and Market Cap are calculated using a close price as of Oct-05-2023


Estimates Snapshot (Current Fiscal Year End: Jun-30-2023 | Currency: CAD)
Periodic Estimates
Current FQ
Current FQ+1
Current FY
Current FY+1
NTM
EPS Normalized
(0.19)
(0.14)
(0.90)
(0.40)
(0.55)
Revenue (mm)
0.00
0.21
0.00
3.56
1.68
EBITDA (mm)
(1.40)
(1.52)
-
-
(6.07)

Forward Multiples (Current FY)

Price/Earnings
NM

Non-Periodic Estimates

Recommendation
Buy (1.00)
Target Price
1.91
Potential Upside
318.01%


Key Professionals
Name
Title
Nanula, Richard D.
CEO &  Executive Chair
Zasitko, Brian 
Chief Financial Officer
Kazeminy, Assad J.
Chief Scientific Officer
Reeves, Scott Michael
Corporate Secretary & Director

Key Board Members
Name
Title
Nanula, Richard D.
CEO &  Executive Chair
Reeves, Scott Michael
Corporate Secretary & Director
Abramowitz, Paul 
Independent Director
Kaiser, Brittany 
Independent Director
Nemeroff, Charles B.
Independent Director
Susin, Livio 
Independent Director


Primary Industry Classification
Pharmaceuticals


Primary Office Location
1321 Blanshard Street Suite 301 | Victoria, BC | V8W 0B6 | Canada
Phone: 778-410-5195   

Current and Pending Investors
DPL Capital Inc., Phyto Partners, Ltd., Roxy Capital, Inc.

Stock Quote and Chart (Currency: CAD)
Last  (Delayed)
 0.50
Market Cap (mm)
8.1
Open
 0.48
Shares Out. (mm)
17.6
Previous Close
 0.46
Float %
64.9%
Change on Day
0.04
Shares Sold Short (mm)
0.1
Change % on Day
9.3%
Dividend Yield %
-
Day High/Low
 0.50/ 0.48
Diluted EPS Excl. Extra Items
(0.94)
52 wk High/Low
 5.47/ 0.41
P/Diluted EPS Before Extra
NM
Volume (mm)
0.08
Avg 3M Dly Vlm (mm)
0.14
Beta 5Y
-


 
Delayed Quote** | Last Updated on Oct-06-2023 12:06 PM (GMT-5)


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Current and Pending Subsidiaries / Investments
Company Name
Business Description
Geography
Primary Industry
LTM Total Rev.($mm)
LFQ Total Assets ($mm)
LFQ Total Debt ($mm)
BlueSky Wellness Inc. (Pending)
BlueSky Wellness Inc. develops a plant based product for creating balance and healthy lifestyle. It provides brands such as amma, and kanabia a CBD hep product that helps in reducing dependence on pharmaceuticals. It  was founded in 2017 and is headquartered in Vancouver, Canada.

United States and Canada
Personal Care Products
-
-
-
TerraCube International Inc.
As of October 4, 2017, TerraCube International Inc. operates as a subsidiary of Lucy Scientific Discovery Inc.

United States and Canada
-
-
-
-
LSDI Manufacturing Inc

United States and Canada
-
-
-
-


Last 5 Transactions
Announced Date
Closed Date
Transaction Type
Role
Target
Buyer/Investors
Sellers
Size($mm)
Sep-12-2023
-
Merger/Acquisition
Buyer
BlueSky Wellness Inc.
Lucy Scientific Discovery Inc. (NasdaqCM:LSDI)

2.56
Jun-05-2023
Cancelled
Merger/Acquisition
Buyer
Pasithea Therapeutics Corp. (NasdaqCM:KTTA)
Lucy Scientific Discovery Inc. (NasdaqCM:LSDI)

22.94
Apr-06-2023
-
Buyback
Target
Lucy Scientific Discovery Inc. (NasdaqCM:LSDI)


-
Jan-21-2022
Feb-8-2023
Public Offering
Target
Lucy Scientific Discovery Inc. (NasdaqCM:LSDI)


7.50
Sep-30-2018
Sep-30-2018
Merger/Acquisition
Buyer
TerraCube International Inc.
Hollyweed North Cannabis, Inc. (nka:Lucy Scientific Discovery Inc. (NasdaqCM:LSDI))

-
* denotes that the relationship is proprietary


Last 5 Key Developments
Date
Event Type
Headline
Sep-28-2023
Delayed SEC Filings
Lucy Scientific Discovery Inc. announced delayed annual 10-K filing
Sep-27-2023
Delistings
Lucy Scientific Discovery Receives Non-Compliance Notice From Nasdaq
Sep-12-2023
M&A Transaction Announcements
Lucy Scientific Discovery Inc. (NasdaqCM:LSDI) entered into an agreement to acquire BlueSky Wellness Inc. for CAD 3.5 million.
Aug-07-2023
End of Lock-Up Period
Certain Common Shares of Lucy Scientific Discovery Inc. are subject to a Lock-Up Agreement Ending on 7-AUG-2023.
Aug-07-2023
End of Lock-Up Period
Certain Stock Options of Lucy Scientific Discovery Inc. are subject to a Lock-Up Agreement Ending on 7-AUG-2023.


Advisors
Most Recent Auditor
Marcum LLP
Public Offering Advisors
Marcum LLP, Tingle Merrett LLP, Troutman Pepper Hamilton Sanders LLP


Most Recent Auditor
Marcum LLP


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
S&P Global Compustat

Oct 05, 2023 04:38 AM
LSDI
Lucy Scientific Discovery Inc 2023_10_05
Reports
14
S&P Global Compustat

Sep 07, 2023 04:41 AM
LSDI
Lucy Scientific Discovery Inc 2023_09_07
Reports
14
S&P Global Compustat

Jul 06, 2023 03:57 AM
LSDI
Lucy Scientific Discovery Inc 2023_07_06
Reports
14
S&P Global Compustat

Jun 01, 2023 05:16 AM
LSDI
Lucy Scientific Discovery Inc 2023_06_01
Reports
14
S&P Global Compustat

May 04, 2023 04:25 AM
LSDI
Lucy Scientific Discovery Inc 2023_05_04
Reports
15
S&P Global Compustat

Apr 06, 2023 04:34 AM
LSDI
Lucy Scientific Discovery Inc 2023_04_06
Reports
15


Ownership Summary

            Top Holders 
Holders by Type
Holder

Common Stock Equivalent Held

% of Total Shares Outstanding

Market Value (CAD in mm)

Position Date


McElvany, Christopher 

1,475,331

8.36

0.9

Feb-13-2023


Abramowitz, Paul 

1,006,180

5.70

0.6

Feb-09-2023


Lazer, Eric 

806,652

4.57

0.5

Feb-09-2023


Lazer, Dean 

791,007

4.48

0.5

Feb-09-2023


Chamberlain, Henry 

753,340

4.27

0.5

Feb-09-2023


Gagnon, Renee 

483,926

2.74

0.3

Feb-09-2023


AdvisorShares Investments, LLC

284,724

1.61

0.2

Jun-30-2023


Jennings, Heather 

280,673

1.59

0.2

Feb-09-2023


K2 & Associates Investment Management Inc.

250,000

1.42

0.2

Jun-30-2023


Nanula, Richard D.

167,216

0.95

0.1

Feb-09-2023



 



Top Buyers
Buyers
Common Stock Equivalent Held
Change
AdvisorShares Investments, LLC
284,724
284,724
Walleye Capital LLC
77,853
38,639

Top Sellers
Sellers
Common Stock Equivalent Held
Change
Nantahala Capital Management, LLC
0
(95,800)
K2 & Associates Investment Management Inc.
250,000
(46,709)
Warberg Asset Management LLC
0
(27,300)
Two Sigma Securities, LLC, Asset Management Arm
0
(18,134)
Virtu Financial LLC, Asset Management Arm
0
(17,639)


S&P Global Ratings Credit Ratings
No S&P Global Ratings Credit Ratings data available. 


News Headlines
Date/Time
Headline
Source
Sep-12
Lucy Scientific Discovery Inc. Announces Acquisition of BlueSky Wellness Inc. in All-Stock Transaction
GlobeNewswire
Sep-07
Lucy Scientific Acquires High Times Intellectual Property, Including Existing Licensing Agreements in All-Stock Transaction 
GlobeNewswire


Company Coverage
This company is not on any Coverage List.

Products
Biological Raw Materials, cGMP Active Pharmaceutical Ingredients, Mindful, Psychedelic Products


Upcoming Events
Date/Time
Type
Nov-09-2023
Estimated Earnings Release Date (S&P Global Derived)
Nov-14-2023
Estimated Earnings Release Date (S&P Global Derived)
* Future Events are subject to change.


Recent Major Filings

Key Filings
Filed On
Period Date
Company Name
Reporting Owner(s)
Source
Form Type
Size
Sep-28-2023
Jun-30-2023
Lucy Scientific Discovery Inc. (NasdaqCM:LSDI)

SEC
NT 10-K
44 KB
Sep-27-2023
Sep-21-2023
Lucy Scientific Discovery Inc. (NasdaqCM:LSDI)

SEC
8-K (3.01, 9.01)
201 KB
Sep-12-2023
Sep-12-2023
Lucy Scientific Discovery Inc. (NasdaqCM:LSDI)

SEC
8-K (1.01, 3.02, 7.01, 9.01)
649 KB
Sep-08-2023
-
Lucy Scientific Discovery Inc. (NasdaqCM:LSDI)
Lucy Scientific Discovery Inc. (NasdaqCM:LSDI)
SEC
425
242 KB
Sep-08-2023
Sep-06-2023
Lucy Scientific Discovery Inc. (NasdaqCM:LSDI)

SEC
8-K (1.01, 3.02, 7.01, 9.01)
470 KB
Jul-28-2023
Jul-24-2023
Lucy Scientific Discovery Inc. (NasdaqCM:LSDI)

SEC
8-K (5.02, 9.01)
197 KB
Jul-07-2023
Jun-30-2023
Lucy Scientific Discovery Inc. (NasdaqCM:LSDI)

SEC
8-K (1.01, 2.01, 3.02, 9.01)
258 KB
Jun-06-2023
-
Lucy Scientific Discovery Inc. (NasdaqCM:LSDI)
Lucy Scientific Discovery Inc. (NasdaqCM:LSDI)
SEC
425
32 KB
Jun-06-2023
Jun-05-2023
Lucy Scientific Discovery Inc. (NasdaqCM:LSDI)

SEC
8-K (8.01, 9.01)
214 KB
May-10-2023
Mar-31-2023
Lucy Scientific Discovery Inc. (NasdaqCM:LSDI)

SEC
10-Q
5 MB


Insider Trades
Holder Name
Trade Date Range
Security Type
Transacted Shares
Transaction Value Range (CAD)
Transaction Type
% Change
Source
Susin, Livio  (Independent Director)
Feb-13-2023
Common Shares
9,309
30,558
Other Acquisition
7.42
Form 4
Kazeminy Ph.D., Assad J. (Chief Scientific Officer)
Feb-13-2023
Common Shares
85,000
279,027
Other Acquisition
New
Form 4
McElvany, Christopher  (Former President, CEO & Director)
Feb-13-2023
Common Shares
118,403
388,678
Other Acquisition
8.73
Form 4
McElvany, Christopher  (Former President, CEO & Director)
Feb-13-2023
Common Shares
366,187
1,202,072
Derivative Exercise and Retained Stock
33.02
Form 4
Excluding Automatic Transactions
Key Board Members Details
Name
Title
Phone
Fax
Email
Nanula, Richard D.
CEO &  Executive Chair
-
-

Reeves, Scott Michael
Corporate Secretary & Director
(403) 571-8000
(403) 571-8008

Abramowitz, Paul 
Independent Director
-
-

Kaiser, Brittany 
Independent Director
-
-

Nemeroff, Charles B.
Independent Director
-
-

Susin, Livio 
Independent Director
(604) 789-2410
-
liviotravel@gmail.com
* denotes that the relationship is proprietary

Key Executives and Professionals Details
Name
Title
Phone
Fax
Email
Nanula, Richard D.
CEO &  Executive Chair
-
-

Zasitko, Brian 
Chief Financial Officer
-
-

Kazeminy, Assad J.
Chief Scientific Officer
-
-

Reeves, Scott Michael
Corporate Secretary & Director
(403) 571-8000
(403) 571-8008

* denotes that the relationship is proprietary

Historical Equity Pricing Data supplied by Interactive Data Pricing and Reference Data LLC 
S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 

**Intraday Quotes are delayed by at least 20 minutes.
